Paul Lange, MD
Hospitalist · Johnson City, TNNPI 1578537882
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$482
- AbbVie$339
- Lilly USA, LLC$318
- AstraZeneca$190
- Pfizer$136
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$89
- plus $571 from 15 others
What the payments were for
- Food & beverage$2,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $482 |
| AbbVie | 18 | $339 |
| Lilly USA, LLC | 16 | $318 |
| AstraZeneca | 11 | $190 |
| Pfizer | 8 | $136 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $89 |
| GSK | 5 | $89 |
| Bayer | 4 | $80 |
| Exact Sciences | 4 | $65 |
| Amgen | 4 | $57 |
| Medtronic | 2 | $57 |
| Eisai Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Ardelyx, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Inogen, Inc. | 3 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$2,125 in reported general payments places this provider in the 90th percentile of 349 hospitalist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 104 | $165,018 |
| EliquisApixaban | 123 | $112,352 |
| FarxigaDapagliflozin Propanediol | 94 | $61,335 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $54,116 |
| JardianceEmpagliflozin | 47 | $48,947 |
| XifaxanRifaximin | 11 | $37,612 |
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $30,698 |
| LinzessLinaclotide | 46 | $30,591 |
| TrulicityDulaglutide | 23 | $27,109 |
| XareltoRivaroxaban | 21 | $25,718 |
| VraylarCariprazine Hcl | 12 | $17,824 |
| Repatha SyringeEvolocumab | 30 | $16,351 |
| Repatha SureclickEvolocumab | 17 | $14,895 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $13,856 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $13,350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $482 | $165,018104 claims |
| PfizerEliquis | $136 | $112,352123 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $190 | $79,112126 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $89 | $61,21168 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $20 | $60,24064 claims |
| AbbVieLinzess, Vraylar | $339 | $48,41558 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $89 | $37,61211 claims |
| Lilly USA, LLCTrulicity | $318 | $27,10923 claims |
| Astellas Pharma US IncMyrbetriq | $24 | $8,39515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 349 hospitalist providers in Tennessee.
Other hospitalist in Johnson City
- Gerald OnuohaNashville$37K
- Sunil KripalaniNashville$23K
- Ankur SethMemphis$13K
- Eugene ScobeyMemphis$6K
- Monico BanezJackson$6K
- Omar AlsharifKnoxville$6K
- Matthew JosephNashville$5K
- Courtney TafesseMurfreesboro$5K
- Arnel PaneloNashville$5K
- Ravi MishraNashville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.